TRAK Stock Forecast 2025-2026
Distance to TRAK Price Targets
TRAK Price Momentum
10 Quality Stocks Worth Considering Now
Researching ReposiTrak (TRAK) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on TRAK and similar high-potential opportunities.
Latest TRAK Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, TRAK has a bullish consensus with a median price target of $24.00 (ranging from $24.00 to $24.00). Currently trading at $19.56, the median forecast implies a 22.7% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Thomas Forte at Maxim Group, projecting a 22.7% upside. Conversely, the most conservative target is provided by Thomas Forte at Maxim Group, suggesting a 22.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
TRAK Analyst Ratings
TRAK Price Target Range
Latest TRAK Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for TRAK.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 22, 2024 | Maxim Group | Thomas Forte | Buy | Initiates | $24.00 |
| May 22, 2023 | DA Davidson | Buy | Maintains | $0.00 | |
| May 16, 2023 | DA Davidson | Buy | Maintains | $0.00 | |
| May 8, 2023 | DA Davidson | Buy | Maintains | $0.00 | |
| May 17, 2022 | DA Davidson | Buy | Maintains | $0.00 | |
| Feb 15, 2022 | DA Davidson | Buy | Maintains | $0.00 | |
| Nov 16, 2021 | DA Davidson | Buy | Maintains | $0.00 | |
| Sep 6, 2017 | DA Davidson | Buy | Initiates | $0.00 | |
| Aug 2, 2017 | Loop Capital | Buy | Initiates | $0.00 | |
| Jul 27, 2015 | Wells Fargo | Market Perform | Downgrade | $0.00 | |
| Jun 16, 2015 | JP Morgan | Neutral | Downgrade | $0.00 | |
| Jun 16, 2015 | Barclays | Equal-Weight | Upgrade | $62.00 | |
| Jun 15, 2015 | Stifel Nicolaus | Hold | Downgrade | $0.00 | |
| Jun 15, 2015 | Stifel | Hold | Downgrade | $0.00 | |
| Jun 15, 2015 | Craig-Hallum | Hold | Downgrade | $63.25 | |
| Jun 15, 2015 | Barrington Research | Underperform | Downgrade | $0.00 | |
| Apr 8, 2015 | B of A Securities | Neutral | Initiates | $43.00 | |
| Apr 8, 2015 | Bank of America | Neutral | Initiates | $0.00 | |
| Feb 24, 2015 | Barclays | Underweight | Maintains | $43.00 | |
| Feb 20, 2015 | Evercore ISI Group | Buy | Assumes | $52.00 |
ReposiTrak, Inc. (TRAK) Competitors
The following stocks are similar to ReposiTrak based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ReposiTrak, Inc. (TRAK) Financial Data
ReposiTrak, Inc. has a market capitalization of $357.39M with a P/E ratio of 61.1x. The company generates $21.20M in trailing twelve-month revenue with a 29.9% profit margin.
Revenue growth is +7.1% quarter-over-quarter, while maintaining an operating margin of +24.6% and return on equity of +13.5%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
ReposiTrak, Inc. (TRAK) Business Model
About ReposiTrak, Inc.
Provides supply chain and compliance management solutions.
ReposiTrak, Inc. generates revenue by offering technology solutions that enhance supply chain efficiency and compliance for businesses, primarily in the food and pharmaceutical sectors. The company's platform automates compliance and document management processes, allowing clients to reduce costs and manage risks effectively.
With an emphasis on data analytics, ReposiTrak helps clients make informed decisions and optimize operations, ensuring product safety and regulatory adherence. The company's innovative technology is crucial for businesses to meet industry standards, making it a key player in the evolving supply chain landscape.
Company Information
Sector
Technology
Industry
Software - Application
Employees
73
CEO
Mr. Randall K. Fields
Country
United States
IPO Year
1998
Website
repositrak.comReposiTrak, Inc. (TRAK) Latest News & Analysis
Fifty suppliers are set to join ReposiTrak for its hardware-free traceability solutions ahead of regulatory deadlines.
The addition of 50 suppliers to ReposiTrak enhances its market position in traceability solutions, potentially driving revenue growth and improving supply chain efficiency, which can influence stock performance.
ReposiTrak Adds 60 New Food Suppliers to the Queue for the Rapidly Expanding Food Traceability Network
12 days agoSixty suppliers are set to join ReposiTrak for its hardware-free traceability solutions ahead of regulatory deadlines.
The addition of 60 suppliers to ReposiTrak enhances its market position in traceability solutions, potentially increasing revenue and attracting more clients, positively impacting stock performance.
ReposiTrak Adds 50 New Food Suppliers to the Queue for the Rapidly Expanding Food Traceability Network
26 days agoReposiTrak (NYSE: TRAK) adds 50 grocery suppliers to its Traceability Network, enhancing FDA-required data exchange for supply chain tracking and compliance.
ReposiTrak's expansion with 50 new grocery suppliers enhances its market position and strengthens its traceability network, potentially boosting revenue and improving investor confidence.
ReposiTrak, Inc. (NYSE: TRAK) will hold its Q2 2025 earnings conference call on February 12, 2025, at 4:15 PM ET, featuring CEO Randy Fields and CFO John Merrill.
The earnings call for ReposiTrak could reveal key financial performance metrics and strategic insights, impacting stock valuation and investor sentiment around the company.
ReposiTrak (NYSE: TRAK) reported a 7% revenue increase to $5.5 million for FQ2 2025, up from $5.1 million, with recurring revenue rising 5%.
ReposiTrak's revenue growth and increased recurring revenue signal strong demand and stability, which can enhance investor confidence in its financial health and growth potential.
60 suppliers are set to join ReposiTrak for its hardware-free traceability solutions ahead of regulatory deadlines.
The addition of 60 suppliers to ReposiTrak enhances its market position in traceability, potentially boosting revenue and attracting more clients amid regulatory pressures.
Frequently Asked Questions About TRAK Stock
What is ReposiTrak, Inc.'s (TRAK) stock forecast for 2025?
Based on our analysis of 2 Wall Street analysts, ReposiTrak, Inc. (TRAK) has a median price target of $24.00. The highest price target is $24.00 and the lowest is $24.00.
Is TRAK stock a good investment in 2025?
According to current analyst ratings, TRAK has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $19.56. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for TRAK stock?
Wall Street analysts predict TRAK stock could reach $24.00 in the next 12 months. This represents a 22.7% increase from the current price of $19.56. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is ReposiTrak, Inc.'s business model?
ReposiTrak, Inc. generates revenue by offering technology solutions that enhance supply chain efficiency and compliance for businesses, primarily in the food and pharmaceutical sectors. The company's platform automates compliance and document management processes, allowing clients to reduce costs and manage risks effectively.
What is the highest forecasted price for TRAK ReposiTrak, Inc.?
The highest price target for TRAK is $24.00 from Thomas Forte at Maxim Group, which represents a 22.7% increase from the current price of $19.56.
What is the lowest forecasted price for TRAK ReposiTrak, Inc.?
The lowest price target for TRAK is $24.00 from Thomas Forte at Maxim Group, which represents a 22.7% increase from the current price of $19.56.
What is the overall TRAK consensus from analysts for ReposiTrak, Inc.?
The overall analyst consensus for TRAK is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $24.00.
How accurate are TRAK stock price projections?
Stock price projections, including those for ReposiTrak, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
